Literature DB >> 7944837

Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy.

R Klein1, B E Klein, S E Moss, K J Cruickshanks.   

Abstract

BACKGROUND: The object was to examine the relationship of hyperglycemia, as measured by glycosylated hemoglobin level, to the incidence and progression of diabetic retinopathy over a 10-year period.
METHODS: Patients who were younger (n = 682) and older (n = 834) than 30 years at onset of diabetes participated in baseline (1980-1982) and follow-up (1984-1986 and 1990-1992) examinations of a population-based cohort study. Glycosylated hemoglobin levels were measured by microcolumn. Retinopathy was determined from stereoscopic fundus photographs.
RESULTS: Persons with glycosylated hemoglobin levels in the highest quartile at baseline were more likely to have progression of retinopathy than persons with levels in the lowest quartile (younger-onset group: relative risk [RR], 2.9; 95% confidence interval [CI], 2.3 to 3.5; older-onset group taking insulin: RR, 2.1; 95% CI, 1.6 to 2.8; and older-onset group not taking insulin: RR, 4.3; 95% CI, 3.0 to 6.2) and were more likely to develop proliferative diabetic retinopathy (younger-onset group: RR, 7.1; 95% CI, 4.6 to 11.1; older-onset group taking insulin: RR, 3.1; 95% CI, 1.5 to 6.1; and older-onset group not taking insulin: RR, 13.8; 95% CI, 4.8 to 39.5). These relations were significant (P < .005) in all groups examined, even after controlling for other risk variables.
CONCLUSIONS: These data are compatible with the hypothesis that long-term control of hyperglycemia, as measured by glycosylated hemoglobin levels, is a significant risk factor for the long-term progression of diabetic retinopathy and that lower levels of glycosylated hemoglobin, even later in the course of diabetes, may modify the risk imposed by higher levels earlier in the course of disease in people with both younger- and older-onset diabetes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944837

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  56 in total

1.  miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins.

Authors:  Eun-Ah Ye; Li Liu; Jena J Steinle
Journal:  Vision Res       Date:  2017-08-07       Impact factor: 1.886

2.  Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients.

Authors:  C Giusti; R Schiaffini; C Brufani; A Pantaleo; E M Vingolo; P Gargiulo
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

3.  Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.

Authors:  Faramarz Ismail-Beigi; Timothy E Craven; Patrick J O'Connor; Diane Karl; Jorge Calles-Escandon; Irene Hramiak; Saul Genuth; William C Cushman; Hertzel C Gerstein; Jeffrey L Probstfield; Lois Katz; Ulrich Schubart
Journal:  Kidney Int       Date:  2011-12-14       Impact factor: 10.612

4.  There is level 1 evidence for intensive glycemic control for reducing the progression of diabetic retinopathy in persons with type 2 diabetes.

Authors:  Emily Y Chew
Journal:  Endocrine       Date:  2015-02-27       Impact factor: 3.633

Review 5.  Genetics of diabetic retinopathy.

Authors:  Heeyoon Cho; Lucia Sobrin
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

6.  Near-Normalization of Glucose and Microvascular Diabetes Complications: Data from ACCORD and ADVANCE.

Authors:  Patrick J O'Connor; Faramarz Ismail-Beigi
Journal:  Ther Adv Endocrinol Metab       Date:  2011-02       Impact factor: 3.565

7.  Gastric electrical stimulation with the TANTALUS System in obese type 2 diabetes patients: effect on weight and glycemic control.

Authors:  Claudia P Sanmiguel; Jeffrey L Conklin; Scott A Cunneen; Philip Barnett; Edward H Phillips; Mark Kipnes; John Pilcher; Edy E Soffer
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

8.  Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility--Reykjavik Study (AGES-R).

Authors:  E Gunnlaugsdottir; S Halldorsdottir; R Klein; G Eiriksdottir; B E Klein; R Benediktsson; T B Harris; L J Launer; T Aspelund; V Gudnason; M F Cotch; F Jonasson
Journal:  Diabetologia       Date:  2011-12-02       Impact factor: 10.122

9.  Diabetic retinopathy in a multi-ethnic cohort in the United States.

Authors:  Tien Yin Wong; Ronald Klein; F M Amirul Islam; Mary Frances Cotch; Aaron R Folsom; Barbara E K Klein; A Richey Sharrett; Steven Shea
Journal:  Am J Ophthalmol       Date:  2006-03       Impact factor: 5.258

10.  Evaluation of AC(n) and C(-106)T polymorphisms of the aldose reductase gene in Brazilian patients with DM1 and susceptibility to diabetic retinopathy.

Authors:  Flávio Richeti; Renata Maria Noronha; Ricardo Temudo Lessa Waetge; José Paulo Cabral de Vasconcellos; Osías Francisco de Souza; Bianca Kneipp; Nilma Assis; Mylene Neves Rocha; Luís Eduardo Procópio Calliari; Carlos Alberto Longui; Osmar Monte; Monica Barbosa de Melo
Journal:  Mol Vis       Date:  2007-05-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.